365Telugu.com online news, Delhi, 17th January 2025: Jivi AI, a pioneer in AI-driven healthcare solutions, has launched the world’s first free HMPV Risk Assessment Tool to address the growing concerns surrounding the Human Metapneumovirus (HMPV).
This cutting-edge tool provides individuals with a quick and reliable evaluation of their risk levels, empowering them to seek timely medical attention without undue panic.
HMPV, a respiratory virus that significantly impacts children, the elderly, and immunocompromised individuals, has seen a sharp increase in cases. Traditional diagnostic systems often face logistical hurdles, resulting in delays that can compromise patient outcomes. By introducing an AI-driven solution like the Jivi HMPV Risk Assessment Tool, healthcare is becoming more accessible, accurate, and responsive.
This AI-powered tool is designed for global accessibility, functioning directly on smartphones through an intuitive three-step process. Users input symptoms, vital health parameters, and answer targeted questions to build a detailed health profile.
One of the standout features is its ability to monitor heart rate without any wearable device—using only the phone’s front camera. This sensorless innovation highlights the potential of AI in simplifying diagnostics.
Key Features and Benefits:
- Multilingual Support: Available in 14 languages, covering over 90% of the global population.
- Speed: Provides assessments in minutes, enabling quicker decision-making.
- Cost-Free: In line with Jivi AI’s mission to democratize healthcare, the tool is completely free for users worldwide.
At the heart of this tool lies Jivi MedX, an advanced large language model (LLM) trained on an extensive repository of medical data, including books, journals, research studies, and clinical notes. This robust foundation is refined with continuous input from in-house doctors and medical professionals.
Jivi MedX has achieved a remarkable accuracy score of 91.65% across nine benchmark tests, outperforming other AI leaders such as Google’s Med-PaLM 2 and OpenAI’s GPT-4 in healthcare diagnostics. This ensures that users receive highly accurate and reliable risk assessments.
Jivi AI emphasizes the integration of AI innovation with real-world medical expertise. Nearly 40% of its workforce comprises medical professionals, including physicians and surgeons, who validate the tool’s performance and ensure it aligns with clinical standards.
With the rise in HMPV cases, Jivi AI’s HMPV Risk Assessment Tool offers a glimpse into the future of diagnostics-accessible, patient-centered, and driven by innovation. This initiative bridges the gap between technology and healthcare, ensuring individuals receive timely and effective care when it matters most.